Technology News and Research

RSS

U-M hopes to make concept of recycling pacemakers a life-saving reality

Millions worldwide die each year because they can't afford a pacemaker. Meanwhile heart patients in the United States say they'd be willing to donate theirs after death to someone in need.

20 Oct 2010

NCI awards 20/20 GeneSystems $3 million to develop tests for targeted cancer therapies

20/20 GeneSystems, Inc. announced today at the AdvaMed MedTech Conference in Washington, D.C. that the company has been awarded nearly $3 million in grants from the National Cancer Institute's (NCI) Small Business Innovative Research (SBIR) Program to develop tests to help oncologists predict the effectiveness of targeted cancer therapies.

20 Oct 2010

Sysmex America enters contract agreement with Amerinet

Sysmex, a global leader in medical diagnostic testing equipment and information systems technology, today announced a three-year, dual source hematology contract agreement with Amerinet.

From Sysmex America, Inc. 20 Oct 2010

AU launches African women's decade project to improve health, development

Delegates from around the world attended the launch of the African Women's Decade, 2010-2020, (AWD) at an event in Nairobi, Kenya, on Friday, the Kenya Broadcasting Corporation reports.

20 Oct 2010

BIOTRONIK EHR DataSync software offers advanced patient management capabilities

BIOTRONIK SE Co. & KG, a leading manufacturer of implantable cardiac devices, has announced the European release of BIOTRONIK EHR DataSync. The software supports physicians, hospitals and clinics by integrating routine follow-up details, BIOTRONIK Home Monitoring remote follow-up information and data from the company's cardiac device programmers - ICS 3000 and the new programmer, Renamic, soon to be launched across Europe.

20 Oct 2010

New 3D Body Volume Index measurement calculates obesity risk

A new obesity measurement for the 21st Century, which can help identify individuals at risk of illness such as heart disease, strokes and diabetes, has been officially launched.

20 Oct 2010

Pearl announces $69 million Series C financing round

Pearl Therapeutics Inc., a privately held company developing clinically differentiated combination therapies for the treatment of highly prevalent chronic respiratory diseases, including chronic obstructive pulmonary disease (COPD), today announced a $69 million Series C financing. The financing round was led by Vatera Healthcare Partners and included existing investors, Clarus Ventures, New Leaf Venture Partners and 5AM Ventures.

20 Oct 2010

En Ze Jia Shi Pharmaceuticals receives patent for controlled-release oral gliclazide

Lotus Pharmaceuticals, Inc.a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China announced today that its wholly owned subsidiary, En Ze Jia Shi Pharmaceuticals, has been issued a patent by the State Intellectual Property Office of the People's Republic of China for controlled-release oral gliclazide. The patent covers the composition and preparation methods for the drug through 2030.

20 Oct 2010

Researchers to study effectiveness of gamma-tocotrienol on prostate cancer cells

Survival rates of the world's most common cancer might soon be increased with a new vitamin E treatment which could significantly reduce tumour regrowth. Queensland University of Technology (QUT) prostate cancer researchers are leading the fight against a disease which kills 3000 Australian men a year.

20 Oct 2010

ThermoGenesis enters licensing agreement with BioParadox for Res-Q technology

ThermoGenesis Corp. a leading supplier of innovative products and services that process and store adult stem cells, said today it has entered into a license and distribution agreement for its Res-Q 60 BMC (Res-Q) System with BioParadox, Inc., a newly-formed regenerative medicine company focusing on point-of-care cardiovascular therapies.

20 Oct 2010

Opinions: Mdgs in Africa; development maintenance; U.S. efforts to eradicate polio; Global Fund commitment

Addressing the Millennium Development Goals (MDGs) in Africa will not only require extra spending, but also better spending, as well as the improvement of social services and priority setting, Kingsley Alu writes in a Leadership column.

20 Oct 2010

Xenogenics acquires Ideal BioStent assets

MultiCell Technologies, Inc. and its majority owned subsidiary, Xenogenics Corporation, are pleased to announce the acquisition of the Ideal™ BioStent assets by Xenogenics Corporation from investment funds managed by Western Technology Investment and Silicon Valley Bank. Xenogenics Corporation also entered into a worldwide exclusive license with Rutgers University for rights to certain intellectual property related to the Ideal™ BioStent.

19 Oct 2010

MED3OOO acquires Insurance Solutions Group

Today, MED3OOO announced that it has acquired Insurance Solutions Group, Inc., an insurance consulting and brokerage firm based in Wexford, PA. Carl Smollinger, President, and Tom Dean, Vice President of Insurance Solutions Group, will join MED3OOO. Mr. Smollinger will serve as a Senior Vice President over MED3OOO's managed care operations and will remain as President of MED3OOO's Insurance Solutions Group subsidiary. Mr. Dean will continue his role as Vice President of Insurance Solutions Group, Inc.

19 Oct 2010

Pharmacy graduate awarded national recognition for pioneering research in genetics

A young pharmacy graduate has been awarded national recognition for her pioneering research in the field of genetics which has the potential to treat diseases such as cancer and Parkinson's.

19 Oct 2010

TearLab announces publication of CPT code for Osmolarity test

TearLab Corporation announced today that, further to its press release of October 8, 2010, a unique new Current Procedural Terminology code that will apply to the TearLab Osmolarity test has now been published by the American Medical Association. The new code will become effective January 1, 2011.

19 Oct 2010

d-Wise announces opening of office in the UK

d-Wise, provider of powerful business solutions for unique challenges of Life Sciences & Healthcare industries, announced the opening of its office in the UK. The company's UK efforts are spearheaded by James McDermott, a leader and key player in the pharmaceutical and biotechnology outsourcing arena.

19 Oct 2010

Arcadia Biosciences receives Canadian marketing clearance for SONOVA 400 health product

Arcadia Biosciences, Inc., an agricultural technology company focused on developing technologies and products that benefit the environment and human health, today announced that Health Canada has granted the company clearance to sell SONOVA 400 in Canada. With the December 2009 completion of the New Dietary Ingredient (NDI) regulatory process in the United States, Arcadia is now able to make the health-maintaining oil available throughout the US and Canada.

19 Oct 2010

MRG data finds factors that drive single-port laparoscopy market

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, a combination of increased volume from current practitioners and growth in the number of surgeons performing the technique will drive the single-port laparoscopy market to over 100% growth over the next year, and to high double-digit growth past 2011.

19 Oct 2010

ISI launches initiative to create translation glossary for healthcare providers

Phrases like "Grandfathered Health Plan" or "Biosimilar Biological Products" are hard enough to understand in English, let alone trying to accurately translate those concepts into Spanish, Chinese or any other of the dozens of languages in which healthcare providers must communicate.

19 Oct 2010

PC Mall announces new solution for EHR adoption and achievement of meaningful use

PC Mall, Inc., whose healthcare expertise is marketed under the "HealthDynamix" brand, today announced a new solution that supports electronic health record adoption and assists physicians in achieving meaningful use as defined by the US government. Participating physicians will be able to take advantage of EHR funds recently allocated in the American Recovery and Reinvestment Act.

19 Oct 2010

Technology News and Research

U-M hopes to make concept of recycling pacemakers a life-saving reality

NCI awards 20/20 GeneSystems $3 million to develop tests for targeted cancer therapies

Sysmex America enters contract agreement with Amerinet

AU launches African women's decade project to improve health, development

BIOTRONIK EHR DataSync software offers advanced patient management capabilities

New 3D Body Volume Index measurement calculates obesity risk

Pearl announces $69 million Series C financing round

En Ze Jia Shi Pharmaceuticals receives patent for controlled-release oral gliclazide

Researchers to study effectiveness of gamma-tocotrienol on prostate cancer cells

ThermoGenesis enters licensing agreement with BioParadox for Res-Q technology

Opinions: Mdgs in Africa; development maintenance; U.S. efforts to eradicate polio; Global Fund commitment

Xenogenics acquires Ideal BioStent assets

MED3OOO acquires Insurance Solutions Group

Pharmacy graduate awarded national recognition for pioneering research in genetics

TearLab announces publication of CPT code for Osmolarity test

d-Wise announces opening of office in the UK

Arcadia Biosciences receives Canadian marketing clearance for SONOVA 400 health product

MRG data finds factors that drive single-port laparoscopy market

ISI launches initiative to create translation glossary for healthcare providers

PC Mall announces new solution for EHR adoption and achievement of meaningful use

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News